About Us

ACO Name & Location

Augusta Care Partners, LLC
78 Medical Center Drive
Fishersville, VA 22939

ACO Primary Contact

Primary Contact NameMary T. Arrowood
Primary Contact Phone Number(540) 245-7570
Primary Contact Email Addressmarrowood2@augustahealth.com

Organizational Information

ACO Participants

ACO ParticipantsACO Participant in Joint Venture (Enter Y or N)
Shenandoah Emergency Medicine Specialists LLCN
Medical Center Women”s Health, IncN
Gerald ShowalterN
BLUE RIDGE FOOTCARE AND SURGERY PLCN
Augusta Medical GroupN
BLUE RIDGE UROLOGICAL, PCN
COMPREHENSIVE HEALTH SYSTEMS, PLCN
VALLEY COMMUNITY SERVICES BOARDN
Orthopedic Associates, Ltd (D/B/A Shenandoah Valley Orthopedics and Sports Medicine)N
BLUE RIDGE PATHOLOGISTS PCN
Augusta Health Care, Inc.N
Eyeone, PlcN
AUGUSTA SURGERY INCN
SHENANDOAH VALLEY RADIATION ONCOLOGY ASSOCIATES, PCN
AUGUSTA HEALTH CARE FOR WOMEN, PLCN
GERALD SHOWALTER, PSY.D., PCN
Staunton Eye Clinic PLCN

ACO Governing Body

Board of Managers

Member

Member’s Voting Power -Expressed as a percentage or numberMembership TypeACO Participant Legal Business Name/DBA, if Applicable
Last NameFirst NameTitle/Position
OtteniJackVoting Member and Chair1ACO Participant RepresentativeOrthopedic Associates, Ltd (D/B/A Shenandoah Valley Orthopedics and Sports Medicine)
SnyderJohnVoting Member and Vice-Chair1ACO Participant RepresentativeAugusta Medical Group
BarocoPatrickVoting Member and Secretary/Treasurer1ACO Participant RepresentativeAugusta Medical Group
FosnochtDavidVoting Member1ACO Participant RepresentativeShenandoah Emergency Medicine Specialists, LLC
JustScottVoting Member1ACO Participant RepresentativeAugusta Medical Group
MannixMaryVoting Member1ACO Participant RepresentativeAugusta Health Care, Inc
MaybeeNellyVoting Member1ACO Participant RepresentativeAugusta Medical Group
FentonBarbaraVoting Member1Medicare Beneficiary Representative

Key ACO Clinical and Administrative Leadership

Daniel O’ConnorACO Executive
Clint Merritt, MDMedical Director
D. Scott JonesCompliance Officer
Clint Merritt, MDQuality Assurance/Improvement Officer

Associated Committees and Committee Leadership

Committee NameCommittee Leader Name and Position
Finance & Network DevelopmentJohn Mattern, DO, Chair
Quality & Care ProcessStephanie Pitsilos, MD, Chair

Types of ACO Participants or Combinations of Participants that Formed the ACO

  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Third Agreement Period
    • Performance year 2020, $1,967,858.07
  • Second Agreement Period
    • Performance Year 2019, $0
    • Performance Year 2018, $0
    • Performance Year 2017, $0
  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 70%
  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2018
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2020 Quality Performance Results

ACO#Measure NameRateACO Mean
ACO-43Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91)0.780.95
ACO-13Falls: Screening for Future Fall Risk98.6884.97
ACO-14Preventive Care and Screening: Influenza Immunization86.1676.03
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention96.8881.67
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan90.3371.46
ACO-19Colorectal Cancer Screening84.2972.59
ACO-20Breast Cancer Screening88.7274.05
ACO-42Statin Therapy for the Prevention and Treatment of Cardiovascular Disease86.2883.37
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control11.5914.70
ACO-28Hypertension (HTN): Controlling High Blood Pressure63.2972.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

N/A